4//SEC Filing
INNOVUS PHARMACEUTICALS, INC. 4
Accession 0001181431-13-035106
CIK 0001411879operating
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 9:30 PM ET
Size
6.2 KB
Accession
0001181431-13-035106
Insider Transaction Report
Form 4
Damaj Bassam
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2013-06-12$0.32/sh+129,393$41,794→ 129,393 total(indirect: By Spouse) - Purchase
Common Stock
2013-06-12$0.32/sh+287,448$92,846→ 5,051,270 total
Footnotes (1)
- [F1]Consists of (a) 250,406 held in the reporting person's name, (b) 4,507,308 shares held together with the reporting person's spouse and (c) 293,556 shares held in the reporting person's IRAs.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001411879
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 9:30 PM ET
- Size
- 6.2 KB